Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in IntangiblesChange in IntangiblesChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesLong-Term Debt IssuancesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetShares IssuedShares OutstandingShares Outstanding
Ratios

Volitionrx (VNRX) Shares Issued (2019 - 2025)

Volitionrx filings provide 9 years of Shares Issued readings, the most recent being $6.7 million for Q4 2025.

  • On a quarterly basis, Shares Issued rose 202.29% to $6.7 million in Q4 2025 year-over-year; TTM through Dec 2025 was $9.1 million, a N/A change, with the full-year FY2025 number at $11.2 million, changed N/A from a year prior.
  • Shares Issued hit $6.7 million in Q4 2025 for Volitionrx, up from $2.4 million in the prior quarter.
  • In the past five years, Shares Issued ranged from a high of $19.4 million in Q2 2021 to a low of -$6.6 million in Q4 2024.
  • Median Shares Issued over the past 5 years was $1.8 million (2021), compared with a mean of $3.7 million.
  • Biggest five-year swings in Shares Issued: soared 581785633.33% in 2023 and later plummeted 353.26% in 2024.
  • Volitionrx's Shares Issued stood at $1.8 million in 2021, then crashed by 56.15% to $781794.0 in 2022, then skyrocketed by 231.59% to $2.6 million in 2023, then plummeted by 353.26% to -$6.6 million in 2024, then surged by 202.29% to $6.7 million in 2025.
  • The last three reported values for Shares Issued were $6.7 million (Q4 2025), $2.4 million (Q1 2025), and -$6.6 million (Q4 2024) per Business Quant data.